SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes…

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance protection against reinfection.

Montana Gov. Greg Gianforte’s administration is reviving efforts to do away with a panel that hears appeals from people who were denied public assistance to afford basics such as food…

Latonia Wilkins knows she needs to be on PrEP due to her non-monogamous lifestyle. But the 52-year-old Atlanta mother has faced repeated challenges getting the lifesaving drug that can prevent…

Facial appearance dissatisfaction is associated with virtual meeting (VM) fatigue, which prompts the use of impression management behaviors and results in lower intention to adopt VM technologies, according to a…

Rice University researchers have revealed novel sequence-structure-property relationships for customizing engineered living materials (ELMs), enabling more precise control over their structure and how they respond to deformation forces like stretching…

MaxCyte, Inc., a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the acquisition of SeQure Dx, a market leader…

The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ensuring diagnostic reliability.

In Brazil, education emerges as the top factor influencing cognitive decline, revealing significant health disparities affecting brain health in Latin America.

Allergies and asthma are widespread diseases that could arise during embryonal development in the womb.